Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC)
Gerrit Van Harskamp, Epie Boven, Jan B. Vermorken, Henk Van Deutekom, Jaap Stam, K. Hian Njo, A. B M F Karim, Anton H. Tierie, Richard P. Golding, Herbert M. Pinedo
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC)'. Together they form a unique fingerprint.